Stevens' Disruptive Technologies Roundtable Series discusses SPOC
VP Helena Wisniewski hosts forum on muscle pain detection device
Hoboken, N.J. -- Dr. Helena S. Wisniewski, Vice President for University Research & Enterprise Development at Stevens Institute of Technology, will host the second in a series of monthly "Disruptive Technologies Roundtables" at Stevens. The luncheon will discuss Stevens Proof of Concept (SPOC), a biomedical technology application for muscle pain detection, on July 26, 2006, 11:30 a.m. to 1:30 p.m. in the 14th Floor Board Room of The Wesley J. Howe
Center, two blocks east of Washington and 8th Streets in Hoboken. Lunch will be served and members of the media are welcome to attend.
The program is a by-invitation roundtable discussion about a revolutionary product that eliminates unnecessary surgery by finding the overlooked source of back and neck pain. The product, recently featured on CBS TV and Eyewitness News, is the basis for the Technogenesis® start-up company, SPOC, LLC. The presentation will include discussions of the technology, the applications, and the business case and demonstration (see Company Executive Summary below).
Each month will focus on a different Stevens' technology that either is ready for commercialization, or is the basis of a Technogenesis start-up company.
"Invited representatives from the investment community and industry will have the opportunity to receive a first-hand look at the technology, meet the inventors, and discuss their assessment of the technology's potential in the marketplace," said Wisniewski. "Our intention is to provide a forum for networking and promoting interaction among industry, the investment community, and the university, leading to joint innovation and enterprise."
For further information, please contact Dr. Wisniewski at firstname.lastname@example.org or 201-216-8210.
About Stevens Proof of Concept
SPOC, a Limited Liability Corporation (LLC), was formed in July 2005 by the Office of University Research and Enterprise Development along with the technology inventors, Dr. Norman Marcus, a leading expert in the field of pain management, and Jeckin Shah, Ryan Stellar and Daniel Silva. In addition to successfully licensing intellectual property and launching start-up companies, Stevens has had several successful liquidity events such as the sale of two of its Technogenesis start ups, Hydroglobe and PlasmaSol, to major corporations.
SPOC was conceived at Stevens as a senior design project in Professor Vikki Hazelwood's Biomedical Senior Design class during the school year 2004 to 2005. Building on the initial meeting Dr. Marcus on October 22, 2004, SPOC developed functional prototypes that were delivered in February 2005 for pre-clinical trials. Currently, the devices are undergoing clinical trails at NYU Medical School. SPOC has developed a clinical and technological platform that promises to greatly increase the accuracy with which muscle pain is diagnosed and drive down health care costs associated with chronic pain.
SPOC incorporates two technologies, one of clinical methodology and one of device technology, for a combined diagnostic package that allows for a revolution in the accuracy and precision of muscle pain diagnosis. The first is a diagnostic method developed over 50 years by a series of key opinion leaders in pain management. Dr. Marcus' patented version of this methodology allows for the diagnosis of muscles in a dynamic, natural state (as opposed to static). This simple feature greatly increases the precision of the diagnosis while the unique methodology provides isolation of the pain generator, increasing accuracy. The device was developed by SPOC and incorporates leading technology for trans-cutaneous-electroneural stimulation, a safe, effective and proven way of stimulating muscle. The patented Dr. Marcus method and the SPOC device are inherently linked, a powerful innovation in the management of chronic pain.
About Stevens Institute of Technology
Established in 1870, Stevens offers baccalaureate, masters and doctoral degrees in engineering, science, computer science, management and technology management, as well as a baccalaureate in the humanities and liberal arts, and in business and technology. Located directly across the Hudson River from Manhattan, the university has enrollments of approximately 1,780 undergraduates and 2,700 graduate students, and a current enrollment of 2,250 online-learning students worldwide. Additional information may be obtained from its web page at www.Stevens.edu. For the latest news about Stevens, please visit www.StevensNewsService.com.
Last reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
Published on PsychCentral.com. All rights reserved.